BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23738943)

  • 21. Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis.
    Yuan W; Chen Z; Wu S; Ge J; Chang S; Wang X; Chen J; Chen Z
    Pathol Oncol Res; 2009 Sep; 15(3):473-8. PubMed ID: 19048396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bidirectional signalling between EphA2 and ephrinA1 increases tubular cell attachment, laminin secretion and modulates erythropoietin expression after renal hypoxic injury.
    Rodriguez S; Rudloff S; Koenig KF; Karthik S; Hoogewijs D; Huynh-Do U
    Pflugers Arch; 2016 Aug; 468(8):1433-48. PubMed ID: 27228995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.
    Wykosky J; Debinski W
    Mol Cancer Res; 2008 Dec; 6(12):1795-806. PubMed ID: 19074825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of EphA4 induced by EphrinA1 exacerbates disruption of the blood-brain barrier following cerebral ischemia-reperfusion via the Rho/ROCK signaling pathway.
    Chen F; Liu Z; Peng W; Gao Z; Ouyang H; Yan T; Ding S; Cai Z; Zhao B; Mao L; Cao Z
    Exp Ther Med; 2018 Sep; 16(3):2651-2658. PubMed ID: 30186497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
    Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
    Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term efficacy of robotic radical total gastrectomy for gastric cancer and analysis of prognostic factors].
    Xie SH; Shi Y; Long D; Chen J; Zhao YL; Qian F; Hao YX; Tang B; Li PA; Yu PW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):357-363. PubMed ID: 32306603
    [No Abstract]   [Full Text] [Related]  

  • 28. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation.
    Giorgio C; Hassan Mohamed I; Flammini L; Barocelli E; Incerti M; Lodola A; Tognolini M
    PLoS One; 2011 Mar; 6(3):e18128. PubMed ID: 21479221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
    Tandon M; Vemula SV; Sharma A; Ahi YS; Mittal S; Bangari DS; Mittal SK
    J Gene Med; 2012 Feb; 14(2):77-89. PubMed ID: 22228563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
    Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
    [No Abstract]   [Full Text] [Related]  

  • 32. Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo.
    Yuan W; Chen Z; Chen Z; Wu S; Guo J; Ge J; Yang P; Huang J
    Neoplasma; 2012; 59(1):105-13. PubMed ID: 22103904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EphA4 protein promotes invasion in clear cell renal cell carcinomas.
    Zhou S; Wang L; Guo S; Zhang Z; Wang J
    Int J Clin Exp Pathol; 2017; 10(12):11737-11742. PubMed ID: 31966534
    [No Abstract]   [Full Text] [Related]  

  • 34. EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
    Kamat AA; Coffey D; Merritt WM; Nugent E; Urbauer D; Lin YG; Edwards C; Broaddus R; Coleman RL; Sood AK
    Cancer; 2009 Jun; 115(12):2684-92. PubMed ID: 19396818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis.
    Yang P; Yuan W; He J; Wang J; Yu L; Jin X; Hu Y; Liao M; Chen Z; Zhang Y
    Hepatol Res; 2009 Dec; 39(12):1169-77. PubMed ID: 19788698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis.
    Funk SD; Yurdagul A; Albert P; Traylor JG; Jin L; Chen J; Orr AW
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):686-95. PubMed ID: 22247258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated Expression of EPHA2 Is Associated With Poor Prognosis After Radical Prostatectomy in Prostate Cancer.
    Kurose H; Ueda K; Kondo R; Ogasawara S; Kusano H; Sanada S; Naito Y; Nakiri M; Nishihara K; Kakuma T; Akiba J; Igawa T; Yano H
    Anticancer Res; 2019 Nov; 39(11):6249-6257. PubMed ID: 31704854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers.
    Oki M; Yamamoto H; Taniguchi H; Adachi Y; Imai K; Shinomura Y
    World J Gastroenterol; 2008 Oct; 14(37):5650-6. PubMed ID: 18837080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma.
    Li X; Wang L; Gu JW; Li B; Liu WP; Wang YG; Zhang X; Zhen HN; Fei Z
    Tumour Biol; 2010 Oct; 31(5):477-88. PubMed ID: 20571968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
    Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
    Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.